Sean A. McCarthy, President and CEO at CytomX Therapeutics, Inc. (CTMX), sold 39,156 shares at $26.55 ($1.0M) on 2018-05-01, disclosed to the SEC on 2018-05-02.
Open-market sale of $1.0M CTMX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.55 | 19,578 | $520K | 50.0% |
| 2 | $26.55 | 19,578 | $520K | 50.0% |
| Total | $26.55 avg | 39,156 | $1.0M | 100% |
| Filing → |
| CTMX | SELL | 2025-06-17 | $299K | — | Filing → |
| CTMX | SELL | 2025-03-20 | $23K | — | Filing → |
| CTMX | SELL | 2024-08-22 | $17K | — | Filing → |